MBX Biosciences, Inc. Contracts & Agreements
16 Contracts & Agreements
- Business Finance (5 contracts)
- Business Operations (2)
- Human Resources (7)
- Intellectual Property (1)
- Real Estate (1)
- Form of Underwriting Agreement (Filed With SEC on September 9, 2024)
- Non-Employee Director Compensation Policy (Filed With SEC on September 9, 2024)
- 2024 Stock Option and Incentive Plan and forms of award agreements thereunder (Filed With SEC on August 30, 2024)
- 2024 Employee Stock Purchase Plan (Filed With SEC on August 30, 2024)
- Form of Officer Indemnification Agreement (Filed With SEC on August 30, 2024)
- Form of Director Indemnification Agreement (Filed With SEC on August 30, 2024)
- Senior Cash Incentive Bonus Plan (Filed With SEC on August 30, 2024)
- Non-Employee Director Compensation Policy (Filed With SEC on August 30, 2024)
- Employment Agreement between the Registrant and P. Kent Hawryluk, President and Chief Executive Officer, to be in effect upon the closing of this offering (Filed With SEC on August 30, 2024)
- Employment Agreement between the Registrant and Richard Bartram, Chief Financial Officer, to be in effect upon the closing of this offering (Filed With SEC on August 30, 2024)
- Employment Agreement between the Registrant and Salomon Azoulay, Chief Medical Officer, to be in effect upon the closing of this offering (Filed With SEC on August 30, 2024)
- Second Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated August 2, 2024 (Filed With SEC on August 23, 2024)
- Form of Common Stock Certificate (Filed With SEC on August 23, 2024)
- 2019 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on August 23, 2024)
- Exclusive License Agreement, dated as of June 10, 2020, between Indiana University Research and Technology Corporation and MBX Biosciences, Inc., as amended (Filed With SEC on August 23, 2024)
- Office Lease between Zeller-Carmel Property, L.L.C. and MBX Biosciences, Inc., dated April 28, 2022 (Filed With SEC on August 23, 2024)
